News | Nuclear Imaging | November 15, 2018

GE Healthcare Recalls Millennium Nuclear Medicine Systems

Class I recall initiated due to risk of detector detaching and falling; no patient injuries have been reported

GE Healthcare Recalls Millennium Nuclear Medicine Systems

November 15, 2018 — GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top detector detached and fell onto the detector below it. No patient injuries have been reported, although there remains a risk of potential life-threatening bodily harm if the detector were to detach and fall during a patient exam. The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall.

The Millennium MG, Millennium MC and Millennium Myosight Nuclear Medicine Systems are devices used to take images of a patient’s organs or tissues to help diagnose or treat a health condition or disease. These systems are intended for use as diagnostic imaging devices which allow the user to acquire data for high-resolution, three-dimensional images.

On Sept. 14, 2018, GE Healthcare sent customers an “Urgent Medical Device Correction Letter.” The letter instructed customers to stop using the Millennium MG, Millennium MC, and Millennium Myosight Nuclear Medicine systems until the company could complete a full and free inspection of all systems. On Nov. 6, GE Healthcare reported they had completed inspections on all Millennium MG, Millennium MC and Millennium Myosight Systems and confirmed no related issues were found.

The recall affects a total of 996 devices with the following model/item numbers:

  • NMH817;
  • NMH816;
  • NMH815;
  • NMH814;
  • NMH803;
  • NMH802;
  • NMH801;
  • NMH800;
  • NGS014;
  • NGS012;
  • NGS009;
  • NGS005; and
  • NG00.

All affected devices were manufactured between Jan. 1, 1997 and July 1, 2012, and distributed between Jan. 1, 1997 and Sept. 1, 2018.

  • Manufacturing Dates: January 1, 1997, to July 1, 2012
  • Distribution Dates: January 1, 1997, to September 1, 2018
  • Devices Recalled in the U.S.: 996

GE Healthcare has determined that the incident was caused by an improperly functioning primary motion stopper and a missing mechanical stopper which would limit the detector’s travel beyond its limits during normal operation.

In June 2013,a patient was killed because a portion of a GE Infinia Hawkeye 4 single photon emission computed tomography (SPECT)/computed tomography (CT) scanner fell during the scan at the James J. Peters VA Medical Center in the Bronx, N.Y.  The weight of nuclear imaging cameras are around 1,300 pounds or more due to it being lead-lined, plus additional lead used in the construction of the internal collimation system. This significant weight poses design challenges in these systems because of the fatigue on its supports. It is an issue that all vendors face.

The death prompted the company to initiate a Class I recall of several of its nuclear imaging systems in 2013 so they would be retrofitted with additional support. The recall, which can be read here, was expanded to most of GE’s SPECT/CT systems in July 2013.

Read the article "Patient Killed During Nuclear Imaging Scan."

Healthcare professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Healthcare professionals employed by facilities that are subject to FDA's user facility reporting requirements should follow the reporting procedures established by their facilities.

For more information: www.gehealthcare.com, www.fda.gov

 

Related Content

GE Healthcare Partners With Department of Veterans Affairs to Accelerate 3-D Printing
News | Medical 3-D Printing | December 11, 2018
GE Healthcare and VA Puget Sound Health Care System, Washington, recently announced a partnership to accelerate the use...
Siemens Healthineers Unveils Multix Impact Digital Radiography System at RSNA 2018
News | Digital Radiography (DR) | December 11, 2018
At the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30 in...
Lunit Announces New Prominent Radiology Advisory Board Members
News | Artificial Intelligence | December 11, 2018
Medical artificial intelligence (AI) software company Lunit announced three new members of its advisory board,...
Videos | RSNA | December 11, 2018
Imaging Technology News (ITN) closed out the Radiological Society of...
Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
Coreline Soft Introduces AI Lung Segmentation Solution at RSNA 2018
News | Lung Cancer | December 10, 2018
December 10, 2018 — Korean image software company Coreline Soft Co. Ltd.
FDA Approves New Features for Planmed Verity Cone Beam CT Scanner
Technology | Computed Tomography (CT) | December 07, 2018
The U.S. Food and Drug Administration (FDA) issued an approval letter for the new features and intended uses of the...
Youth Football Changes Nerve Fibers in Brain

Statistically significant clusters (red-colored) showing group differences (Control vs. Football) in white matter strain along the primary (F1) and secondary (F2) fibers. While body of corpus callosum (BBC) showed relative shrinkage in Football group, the other clusters showed relative stretching of fibers. PCR: Posterior Corona Radiata, PLIC: Posterior Limb of Internal Capsule, SCR: Superior Corona Radiata, SLF: Superior Longitudinal Fasciculus, SCC: Splenium of Corpus Callosum. Image courtesy of Kim et al.

News | Neuro Imaging | December 07, 2018
Magnetic resonance imaging (MRI) scans show repetitive blows to the head result in brain changes among youth football...
Hitachi Medical Systems Europe Introduces Third-Generation Intelligent Vector Flow Mapping
News | Cardiovascular Ultrasound | December 07, 2018
Hitachi Medical Systems Europe introduced what it calls the next level of intelligent Vector Flow Mapping (iVFM) at...
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...